Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Revolution Medicines, Inc.
Updated Jul 16, 2026
GOLDSMITH MARK A has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $33.20M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 10.0K | $156.12 | $1.56M |
| 2026-04-17 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 120.0K | $150.09 | $18.01M |
| 2026-04-17 | RVMD | Revolution Medicines, Inc. | M — Option exercise | 96.8K | $4.73 | $458K |
| 2026-04-17 | RVMD | Revolution Medicines, Inc. | M — Option exercise | 23.2K | $4.09 | $95K |
| 2026-03-19 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 12.9K | $99.48 | $1.28M |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 200 | $102.08 | $20K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 2.1K | $101.63 | $213K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 600 | $100.19 | $60K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 100 | $98.29 | $10K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 800 | $102.00 | $82K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 1.7K | $101.47 | $173K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 400 | $100.12 | $40K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 100 | $98.31 | $10K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 851 | $102.20 | $87K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 21.3K | $101.60 | $2.17M |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 3.6K | $100.73 | $365K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 3.5K | $99.76 | $349K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 700 | $98.17 | $69K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | M — Option exercise [10b5-1] | 30.0K | $4.09 | $123K |
| 2026-03-04 | RVMD | Revolution Medicines, Inc. | A — Grant or award [10b5-1] | 57.1K | $0.00 |
GOLDSMITH MARK A is a corporate insider — currently tracked as Insider of Revolution Medicines, Inc. (RVMD). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 27 open-market sales ($33.20M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GOLDSMITH MARK A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.